Associated Papers
Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors.
Jones D et al.
Cancer, 2008
Select a paper to view details
Jones D et al.
Cancer, 2008